Astion Pharma is an emerging specialty pharmaceutical company focusing on research and development of products for the treatment of inflammatory dermatological  diseases. The goal of the company is to become a leading player for prescription pharmaceutical products to treat dermatological diseases.

Astion Pharma has a strong and proprietary technology base for the development of novel innovative anti-inflammatory products.  Astion currently has two clinical development projects in phase 3 within dermatology and a large and diverse portfolio of product candidates and research programmes at earlier stages.